.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research has shed light on the complex nature of nsLTP allergen cross-reactivity through the discovery of a unique human monoclonal antibody, IGX-3103. Nonspecific lipid transfer proteins (nsLTPs) often cause systemic allergic reactions to various plant foods. For clinicians, distinguishing between true cosensitization and broad cross-reactivity in allergic patients is a major diagnostic hurdle. However, this study suggests that a single, promiscuous antibody may drive the multi-source sensitivity seen in many patients. Specifically, researchers cloned IGX-3103 from memory B cells using single-cell sequencing.
Moreover, researchers discovered that this antibody binds to 19 different type 1 nsLTP allergens. In addition, crystallographic analysis showed that the antibody induces a conformational change in the allergen. This allows a specific residue, Phe104, to penetrate the lipid-binding cavity. Because key residues like Leu1 and Ser2 are conserved across plant species, the antibody reacts with allergens from fruits, seeds, and pollens. Thus, this mechanism explains why some patients react to so many different sources.
As a result, the discovery of IGX-3103 confirms that a few promiscuous antibodies can cause widespread food sensitivity. This supports the idea that cross-reactivity often stems from shared epitopes. Consequently, doctors can better understand why patients test positive for multiple unrelated plant extracts. These findings help in developing more precise diagnostic tools. Furthermore, they allow for more personalized management of patients with complex allergy profiles. Therefore, understanding this antibody could improve clinical outcomes significantly.
Non-specific lipid transfer proteins (nsLTPs) are stable plant proteins found in many fruits, vegetables, and nuts. They are highly resistant to heat and digestion, often leading to severe systemic allergic reactions.
IGX-3103 is a promiscuous monoclonal antibody that can bind to many different nsLTPs. Its existence suggests that broad food allergies may be caused by a small number of cross-reactive antibodies rather than many specific ones.
Diagnosis is challenging because the structural similarity between nsLTPs in different foods leads to widespread cross-reactivity. This makes it hard to identify the primary sensitizing food using standard polyclonal serum tests.
Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study identifies IGX-3103, a human monoclonal antibody that binds 19 different nsLTP allergens, explaining the mechanism behind broad food cross-reactivit...
7 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
